Press release: Digital innovation in medicine – Man and machine as ideal combination

Munich, May 18, 2021 – The German Aerosol Therapy Symposium (DATS) and VisionHealth GmbH, pioneer in digital support for inhalation therapy for the treatment of chronic respiratory diseases, have held a webinar on digital innovation about the opportunities and risks of artificial intelligence in the Informed pulmonary medicine.

The central topic of the three lectures was how solutions from the field of smart medicine and artificial intelligence (AI) can support doctors and patients in diagnosing respiratory diseases and in inhalation therapy.

Dr. Sabine Häusermann, CEO and founder of VisionHealth, moderated the webinar and summarized: “It’s refreshing when there are not only AI critics, but also people who see the opportunities offered by technology. However, not all questions in this field have been answered by a long way. We should use the momentum that digital medicine has acquired through the COVID-19 pandemic, among other things, to further develop and use artificial intelligence for the benefit of all of us.”

Aescuvest enables great health innovations through equity investments. It is the leading platform to foster and fund smart healthcare ideas. This independent launch pad offers financing strategies to companies & an above-average profit share to investors.

EIT Health is one of the largest healthcare initatives wordwide. Its goal is to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved wellbeing of people across Europe.

About us

For Investors

For idea providers

Help & legal

Stay tuned

Follow us on

Subscribe to our newsletter

By clicking on ‘Sign up’, you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.